183 related articles for article (PubMed ID: 3940346)
21. [Spontaneous regression of serum HCG in 18 patients following evacuation of uncomplicated androgenic moles].
Vejerslev LO; Arends J; Larsen SO
Ugeskr Laeger; 1988 Aug; 150(35):2081-3. PubMed ID: 3413897
[No Abstract] [Full Text] [Related]
22. Earlier diagnosis and serum human chorionic gonadotropin regression in complete hydatidiform moles.
Kerkmeijer LG; Massuger LF; Ten Kate-Booij MJ; Sweep FC; Thomas CM
Obstet Gynecol; 2009 Feb; 113(2 Pt 1):326-31. PubMed ID: 19155902
[TBL] [Abstract][Full Text] [Related]
23. Recurrent gestational trophoblastic disease after hCG normalization following hydatidiform mole in The Netherlands.
Kerkmeijer LG; Wielsma S; Massuger LF; Sweep FC; Thomas CM
Gynecol Oncol; 2007 Jul; 106(1):142-6. PubMed ID: 17462723
[TBL] [Abstract][Full Text] [Related]
24. Diagnosis of hydatidiform mole and persistent trophoblastic disease: diagnostic accuracy of total human chorionic gonadotropin (hCG), free hCG {alpha}- and {beta}-subunits, and their ratios.
van Trommel NE; Sweep FC; Schijf CP; Massuger LF; Thomas CM
Eur J Endocrinol; 2005 Oct; 153(4):565-75. PubMed ID: 16189178
[TBL] [Abstract][Full Text] [Related]
25. Duration of human chorionic gonadotropin surveillance for partial hydatidiform moles.
Lavie I; Rao GG; Castrillon DH; Miller DS; Schorge JO
Am J Obstet Gynecol; 2005 May; 192(5):1362-4. PubMed ID: 15902109
[TBL] [Abstract][Full Text] [Related]
26. Human chorionic gonadotropin, estradiol, progesterone, prolactin, and B-scan ultrasound monitoring of complications in early pregnancy.
Yuen BH; Livingston JE; Poland BJ; Wittmann BK; Sy L; Cannon W
Obstet Gynecol; 1981 Feb; 57(2):207-14. PubMed ID: 7465126
[TBL] [Abstract][Full Text] [Related]
27. [The serum concentration of specific beta 1-glycoprotein in trophoblastic disease].
Radikov N
Akush Ginekol (Sofiia); 1989; 28(2):15-9. PubMed ID: 2548413
[TBL] [Abstract][Full Text] [Related]
28. Plasma homocysteine, vitamin B12 and folate levels in hydatidiform moles and histopathological subtypes.
Kokanali MK; Oztürkkan D; Unsal N; Möroy P; Güngör T; Mollamahmutoğlu L
Arch Gynecol Obstet; 2008 Dec; 278(6):531-4. PubMed ID: 18379803
[TBL] [Abstract][Full Text] [Related]
29. Disappearance of serum progesterone: after normal delivery and removal of hydatidiform mole.
Dawood MY; Teoh ES
Obstet Gynecol; 1975 Jan; 45(1):9-12. PubMed ID: 1110825
[TBL] [Abstract][Full Text] [Related]
30. [Radioimmunoassay of HCG and HCG beta in blood during pregnancy and trophoblastomas].
Mputu L; Thomas K; Renaer M; Vorstermans M; de Muylder X; Ferin J
J Gynecol Obstet Biol Reprod (Paris); 1977 Sep; 6(6):777-91. PubMed ID: 199644
[TBL] [Abstract][Full Text] [Related]
31. A rapid solid-phase radioimmunoassay specific for human chorionic gonadotropin in gestational trophoblastic disease.
Goldstein DP; Pastorfide GB; Osathanondh R; Kosasa TS
Obstet Gynecol; 1975 May; 45(5):527-30. PubMed ID: 164644
[TBL] [Abstract][Full Text] [Related]
32. [Changes in serum human chorionic gonadotropin in patients with hydatidiform mole following evacuation].
Wang X
Zhonghua Fu Chan Ke Za Zhi; 1988 Nov; 23(6):362-4, 388. PubMed ID: 2854773
[No Abstract] [Full Text] [Related]
33. Persistent trophoblast disease following partial molar pregnancy.
Wielsma S; Kerkmeijer L; Bekkers R; Pyman J; Tan J; Quinn M
Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):119-23. PubMed ID: 16638033
[TBL] [Abstract][Full Text] [Related]
34. Serum free estriol and estriol glucuronide fractions in hydatidiform mole measured by radioimmunoassay.
Dawood MY; Brown JB; Newnam KL
Obstet Gynecol; 1977 Mar; 49(3):303-7. PubMed ID: 840458
[TBL] [Abstract][Full Text] [Related]
35. Low risk of relapse after achieving undetectable HCG levels in women with complete molar pregnancy.
Wolfberg AJ; Feltmate C; Goldstein DP; Berkowitz RS; Lieberman E
Obstet Gynecol; 2004 Sep; 104(3):551-4. PubMed ID: 15339768
[TBL] [Abstract][Full Text] [Related]
36. Gestational Trophoblastic Neoplasia After Human Chorionic Gonadotropin Normalization Following Molar Pregnancy: A Systematic Review and Meta-analysis.
Albright BB; Shorter JM; Mastroyannis SA; Ko EM; Schreiber CA; Sonalkar S
Obstet Gynecol; 2020 Jan; 135(1):12-23. PubMed ID: 31809433
[TBL] [Abstract][Full Text] [Related]
37. First trimester diagnosis of partial mole.
Phupong V; Triratanachat S; Promchainant C; Ultchaswadi P
Arch Gynecol Obstet; 2005 Sep; 272(3):235-7. PubMed ID: 15875207
[TBL] [Abstract][Full Text] [Related]
38. Prediction of persistent gestational trophobalstic neoplasia: the role of hCG level and ratio in 2 weeks after evacuation of complete mole.
Kang WD; Choi HS; Kim SM
Gynecol Oncol; 2012 Feb; 124(2):250-3. PubMed ID: 22094931
[TBL] [Abstract][Full Text] [Related]
39. Hydatidiform moles at Waikato Women's Hospital, 1971-85.
Lowe B; Vant MM
N Z Med J; 1986 Aug; 99(808):624-6. PubMed ID: 3462563
[TBL] [Abstract][Full Text] [Related]
40. Serum granulocyte macrophage colony stimulating factor (GM-CSF) in gestational trophoblastic diseases.
Shaarawy M; el-Shobokshy AS; el-Noury AI
Cytokine; 1995 Feb; 7(2):171-5. PubMed ID: 7540057
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
